News

Hershey Unveils Q3 2024 Results: Challenges and Future Plans

Hershey Unveils Q3 2024 Results: Challenges and Future Plans

Hershey's Third-Quarter Financial Performance Overview

The Hershey Company (NYSE: HSY) has reported its financial results for the third quarter, revealing consolidated net sales of $2,987.5 million, reflecting a decrease of 1.4%. Despite the challenges, the company remains focused on its strategic priorities aimed at enhancing consumer and shareholder value.

Comments from Leadership and Financial Highlights

Michele Buck, the President and Chief Executive Officer of The Hershey Company, conveyed confidence in the brands' resilience, stating, "We believe in the resiliency of our snacking categories and the strength of our brands. While the current inflationary environment, along with high cocoa prices, poses challenges, we are committed to adjusting our strategies to drive growth. Our efforts include market share expansions and enhancing our overall product range across the confectionery and snacking sector."

Third-Quarter 2024 Results Summary

According to the financial statements, Hershey's reported net income for the period was $446.3 million, translating to $2.20 per share—down 12.7% from the previous year. Adjusted earnings per share reached $2.34, declining by 10%. Additionally, organic and constant currency net sales also saw a decrease of 1.0% during this quarter.

Sales Growth Components

The company has outlined specific components contributing to its sales declines, highlighting factors such as decreased volume across particular segments impacting overall performance. The North America Confectionery segment recorded a 0.8% increase in net sales, contrasted with the North America Salty Snacks segment, which faced a significant drop of 15.5% due to volume losses and inventory challenges.

Future Outlook for 2024

For the full year, Hershey has adjusted its guidance for net sales growth, now anticipated to be flat—a revision from the previous expectation of approximately 2%. The reported earnings per share for the year is anticipated to fall between 9% to 6%. Compared to last year's outlook, these updates reflect the optimization of operational efficiency under current market pressures.

Cost Management and Investments

In an effort to mitigate the impact of rising costs, Hershey is enhancing its focus on cost-saving initiatives while investing in the future growth of various operational areas, including digital infrastructure. The Company has estimated capital expenditures of approximately $575 million to $600 million, driven by expansions in their confection capacity and ongoing technology improvements.

Segment Performance Analysis

The financial breakdown reveals varied performance among segments. The North America Confectionery segment showed resilience, but the North America Salty Snacks segment struggled significantly, primarily attributable to execution challenges and the timing of shipments related to inventory replenishment. Internationally, net sales reflected a decrease of 3.9% as competitive pressures affected performance, particularly in key markets like Brazil and Mexico.

Concluding Remarks on Financial Health

Despite the reported challenges, Hershey's leadership is optimistic about the brand’s long-term potential, confident in the strategies being put in place to navigate these turbulent times. Moving into the fourth quarter, the company aims to capitalize on seasonal strengths while implementing necessary adjustments to meet evolving market demands and consumer behaviors. The management is dedicated to driving top-line growth, bolstered by innovative and efficient approaches to their diverse product offerings.

Frequently Asked Questions

What were Hershey's reported sales in Q3 2024?

Hershey reported consolidated net sales of $2,987.5 million in Q3 2024, marking a 1.4% decrease.

How did Hershey's net income change in Q3 2024?

The reported net income was $446.3 million, or $2.20 per share-diluted, which represents a decrease of 12.7% compared to the previous year.

What is the outlook for Hershey's sales growth in 2024?

The company has updated its guidance, expecting sales growth to be flat instead of the previously anticipated 2% increase.

What segments are driving sales performance challenges for Hershey?

The North America Salty Snacks segment has seen a significant 15.5% decrease in net sales, largely due to volume declines related to inventory and execution issues.

What future investments is Hershey planning?

Hershey is planning capital expenditures of approximately $575 million to $600 million to support capacity expansion and technological advancements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Celebree Gains Franchise Momentum: A New Frontier

Updated Category News Views 9

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Continue Reading
New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 11

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 12

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 21

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 14

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Montessori and Tech: A New Era of Integration

Updated Category News Views 13

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 10

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 12

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 10

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 16

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading

Top 5 Most Recently Viewed Articles

Belmont Medical Technologies Welcomes Brian Larkin as New CEO

Updated Category News Views 223

Belmont Medical Technologies Appoints Brian Larkin as CEO Belmont Medical Technologies, renowned for its advanced fluid resuscitation and patient temperature management systems, has made a significant leadership change. Brian Larkin has stepped into the role of Chief Executive Officer, succeeding Brian Ellacott, effective immediately. A respected figure within the medical...

Continue Reading
Elanco Animal Health's Q3 2024 Financial Overview and Insights

Updated Category News Views 75

Elanco Animal Health Q3 2024 Financial Results Elanco Animal Health Incorporated (NYSE: ELAN) recently announced its financial performance for the third quarter of 2024. The revenue for this period reached $1,030 million, reflecting a 4% decrease on a reported basis. However, when adjusted for the impacts of the aqua business divestiture and foreign exchange fluctuations,...

Continue Reading
NetraMark Host Conference Call to Discuss Growth Strategies

Updated Category News Views 142

NetraMark Holdings Inc. Plans Shareholder Conference Call NetraMark Holdings Inc. (CSE: AIAI) (OTCQB: AINMF) is preparing to host a shareholder conference call where they aim to discuss their recent achievements and exciting opportunities. As a leading company in artificial intelligence, NetraMark is transforming the pharmaceutical industry by utilizing AI-powered...

Continue Reading
Annovis Bio to Share Insights on Dementia and Innovative Treatment

Updated Category News Views 70

Annovis Bio's Involvement in Dementia Research Workshops In a significant step towards advancing treatment for neurodegenerative diseases, Annovis Bio Inc. (NYSE: ANVS) has announced that its President and CEO, Dr. Maria Maccecchini, is set to present at a national workshop focused on Dementia with Lewy Bodies (DLB). This event, which will take place online, is sponsored...

Continue Reading
Strategic Acquisition Fuels Growth for SP Manufacturing

Updated Category News Views 205

SP Manufacturing Partners with Ideal Jacobs to Enhance Capabilities SP Manufacturing (SPM), a prominent name in the field of Electronics Manufacturing Services (EMS), has made significant strides by acquiring the operations of Ideal Jacobs (IJA) in Asia. This strategic move is set to bolster SPM's capabilities to serve mission-critical industries, opening doors to new...

Continue Reading